Algorae Pharmaceuticals Limited
LVCLF
$0.0063
$0.000916.67%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -39.68% | -28.60% | -24.21% | -26.47% | 17.74% |
Total Receivables | -34.82% | -22.87% | -55.33% | -56.61% | 177.06% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 9.71% | 29.84% | -- | -- | -- |
Total Current Assets | -38.71% | -27.46% | -23.92% | -26.20% | 21.17% |
|
|||||
Total Current Assets | -38.71% | -27.46% | -23.92% | -26.20% | 21.17% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -69.44% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -38.73% | -27.49% | -24.01% | -26.29% | 21.01% |
|
|||||
Total Accounts Payable | 12.01% | 32.59% | -36.46% | -38.38% | -64.04% |
Total Accrued Expenses | -73.60% | -68.28% | -76.70% | -77.37% | -60.12% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -5.55% | 11.73% | -60.22% | -61.42% | -63.30% |
|
|||||
Total Current Liabilities | -5.55% | 11.73% | -60.22% | -61.42% | -63.30% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -5.55% | 11.73% | -60.22% | -61.42% | -63.30% |
|
|||||
Common Stock & APIC | -9.20% | 7.46% | 1.87% | -1.17% | 3.57% |
Retained Earnings | 7.86% | -9.05% | 1.80% | 4.73% | 1.42% |
Treasury Stock & Other | -18.25% | -3.24% | -86.86% | -87.25% | -82.42% |
Total Common Equity | -40.02% | -29.01% | -19.68% | -22.08% | 32.82% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -40.02% | -29.01% | -19.68% | -22.08% | 32.82% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -40.02% | -29.01% | -19.68% | -22.08% | 32.82% |
|